Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07317596Phase 3Enrolling by invitation
A Phase 3 trial of methylprednisolone injection, hyaluronic acid sodium composite gel for injection in postoperative complications, sponsored by Sana'a University. Started Jun 2024; status: enrolling by invitation.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07317596.